# RH: financial statements, quarterly

RH · NYSE · CIK 1528849 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Jan 31

Pages: [Overview](/companies/rh.md) · [Financials](/companies/rh/financials.md) · [Filings](/companies/rh/filings.md) · [Insiders](/companies/rh/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rh/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-10-28) | Q4 FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q4 FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q4 FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [751](/filings/0001558370-24-016185.md) | [738 d](/filings/0001104659-26-037992.md) | [727](/filings/0001558370-25-008578.md) | [830](/filings/0001558370-25-012015.md) | [812](/filings/0001104659-25-120354.md) | [812 d](/filings/0001104659-26-037992.md) | [814](/filings/0001104659-26-073006.md) | [899](/filings/0001104659-26-106764.md) | [884](/filings/0001104659-25-120354.md) | [843 d](/filings/0001104659-26-037992.md) | [800](/filings/0001104659-26-073006.md) | [922](/filings/0001104659-26-106764.md) |
| Cost of revenue | $m | [411](/filings/0001558370-24-016185.md) | [417 d](/filings/0001104659-26-037992.md) | [411](/filings/0001558370-25-008578.md) | [455](/filings/0001558370-25-012015.md) | [450](/filings/0001104659-25-120354.md) | [450 d](/filings/0001104659-26-037992.md) | [459](/filings/0001104659-26-073006.md) | [490](/filings/0001104659-26-106764.md) | [494](/filings/0001104659-25-120354.md) | [481 d](/filings/0001104659-26-037992.md) | [469](/filings/0001104659-26-073006.md) | [477](/filings/0001104659-26-106764.md) |
| Gross profit | $m | [340](/filings/0001558370-24-016185.md) | [321 d](/filings/0001104659-26-037992.md) | [316](/filings/0001558370-25-008578.md) | [375](/filings/0001558370-25-012015.md) | [361](/filings/0001104659-25-120354.md) | [363 d](/filings/0001104659-26-037992.md) | [355](/filings/0001104659-26-073006.md) | [409](/filings/0001104659-26-106764.md) | [390](/filings/0001104659-25-120354.md) | [361 d](/filings/0001104659-26-037992.md) | [331](/filings/0001104659-26-073006.md) | [445](/filings/0001104659-26-106764.md) |
| Selling, general and administrative | $m | [289](/filings/0001558370-24-016185.md) | [257 d](/filings/0001104659-26-037992.md) | [261](/filings/0001558370-25-008578.md) | [279](/filings/0001558370-25-012015.md) | [260](/filings/0001104659-25-120354.md) | [292 d](/filings/0001104659-26-037992.md) | [299](/filings/0001104659-26-073006.md) | [280](/filings/0001104659-26-106764.md) | [284](/filings/0001104659-25-120354.md) | [265 d](/filings/0001104659-26-037992.md) | [297](/filings/0001104659-26-073006.md) | [337](/filings/0001104659-26-106764.md) |
| Operating income | $m | [51.2](/filings/0001558370-24-016185.md) | [64.3 d](/filings/0001104659-26-037992.md) | [54.7](/filings/0001558370-25-008578.md) | [96.1](/filings/0001558370-25-012015.md) | [101](/filings/0001104659-25-120354.md) | [70.3 d](/filings/0001104659-26-037992.md) | [55.9](/filings/0001104659-26-073006.md) | [129](/filings/0001104659-26-106764.md) | [106](/filings/0001104659-25-120354.md) | [96.6 d](/filings/0001104659-26-037992.md) | [34.2](/filings/0001104659-26-073006.md) | [108](/filings/0001104659-26-106764.md) |
| Interest expense | $m | [54.6](/filings/0001558370-24-016185.md) | [99.0 d](/filings/0001558370-24-004248.md) | [56.8](/filings/0001558370-24-009145.md) | [59.3](/filings/0001558370-24-012768.md) | [57.6](/filings/0001558370-24-016185.md) | [60.9 d](/filings/0001104659-26-037992.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(9.2)](/filings/0001558370-24-016185.md) | [(6.4) d](/filings/0001104659-26-037992.md) | [(2.1)](/filings/0001558370-25-008578.md) | [3.7](/filings/0001558370-25-012015.md) | [9.3](/filings/0001104659-25-120354.md) | [(6.1) d](/filings/0001104659-26-037992.md) | [3.1](/filings/0001104659-26-073006.md) | [19.0](/filings/0001104659-26-106764.md) | [11.6](/filings/0001104659-25-120354.md) | [13.4 d](/filings/0001104659-26-037992.md) | [(5.9)](/filings/0001104659-26-073006.md) | [16.2](/filings/0001104659-26-106764.md) |
| Net income | $m | [(2.2)](/filings/0001558370-24-016185.md) | [11.4 d](/filings/0001104659-26-037992.md) | [(3.6)](/filings/0001558370-25-008578.md) | [29.0](/filings/0001558370-25-012015.md) | [33.2](/filings/0001104659-25-120354.md) | [13.9 d](/filings/0001104659-26-037992.md) | [8.0](/filings/0001104659-26-073006.md) | [51.7](/filings/0001104659-26-106764.md) | [36.3](/filings/0001104659-25-120354.md) | [28.8 d](/filings/0001104659-26-037992.md) | [(13.7)](/filings/0001104659-26-073006.md) | [60.2](/filings/0001104659-26-106764.md) |
| Diluted EPS | $ per share | [(0.12)](/filings/0001558370-24-016185.md) | not reported | [(0.20)](/filings/0001558370-25-008578.md) | [1.45](/filings/0001558370-25-012015.md) | [1.66](/filings/0001104659-25-120354.md) | not reported | [0.40](/filings/0001104659-26-073006.md) | [2.62](/filings/0001104659-26-106764.md) | [1.83](/filings/0001104659-25-120354.md) | not reported | [(0.73)](/filings/0001104659-26-073006.md) | [3.06](/filings/0001104659-26-106764.md) |
| Basic EPS | $ per share | [(0.12)](/filings/0001558370-24-016185.md) | not reported | [(0.20)](/filings/0001558370-25-008578.md) | [1.57](/filings/0001558370-25-012015.md) | [1.79](/filings/0001104659-25-120354.md) | not reported | [0.43](/filings/0001104659-26-073006.md) | [2.76](/filings/0001104659-26-106764.md) | [1.93](/filings/0001104659-25-120354.md) | not reported | [(0.73)](/filings/0001104659-26-073006.md) | [3.18](/filings/0001104659-26-106764.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-10-28) | FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [381](/filings/0001558370-24-016185.md) | [124](/filings/0001104659-26-037992.md) | [102](/filings/0001558370-24-009145.md) | [78.3](/filings/0001558370-24-012768.md) | [87.0](/filings/0001558370-24-016185.md) | [30.4](/filings/0001104659-26-037992.md) | [46.1](/filings/0001558370-25-008578.md) | [34.6](/filings/0001558370-25-012015.md) | [43.1](/filings/0001104659-25-120354.md) | [41.2](/filings/0001104659-26-106764.md) | [53.8](/filings/0001104659-26-073006.md) | [125](/filings/0001104659-26-106764.md) |
| Current assets | $m | [1,287](/filings/0001558370-23-019631.md) | [1,102](/filings/0001558370-25-004329.md) | [1,116](/filings/0001558370-24-009145.md) | [1,219](/filings/0001558370-24-012768.md) | [1,278](/filings/0001558370-24-016185.md) | [1,291](/filings/0001104659-26-037992.md) | [1,280](/filings/0001558370-25-008578.md) | [1,202](/filings/0001558370-25-012015.md) | [1,124](/filings/0001104659-25-120354.md) | [1,108](/filings/0001104659-26-106764.md) | [1,124](/filings/0001104659-26-073006.md) | [1,159](/filings/0001104659-26-106764.md) |
| Total assets | $m | [4,241](/filings/0001558370-23-019631.md) | [4,144](/filings/0001558370-25-004329.md) | [4,187](/filings/0001558370-24-009145.md) | [4,376](/filings/0001558370-24-012768.md) | [4,464](/filings/0001558370-24-016185.md) | [4,555](/filings/0001104659-26-037992.md) | [4,650](/filings/0001558370-25-008578.md) | [4,697](/filings/0001558370-25-012015.md) | [4,794](/filings/0001104659-25-120354.md) | [4,836](/filings/0001104659-26-106764.md) | [4,948](/filings/0001104659-26-073006.md) | [5,131](/filings/0001104659-26-106764.md) |
| Current liabilities | $m | [935](/filings/0001558370-23-019631.md) | [873](/filings/0001558370-25-004329.md) | [936](/filings/0001558370-24-009145.md) | [1,011](/filings/0001558370-24-012768.md) | [896](/filings/0001558370-24-016185.md) | [905](/filings/0001104659-26-037992.md) | [934](/filings/0001558370-25-008578.md) | [954](/filings/0001558370-25-012015.md) | [946](/filings/0001104659-25-120354.md) | [931](/filings/0001104659-26-106764.md) | [997](/filings/0001104659-26-073006.md) | [1,033](/filings/0001104659-26-106764.md) |
| Total liabilities | $m | [4,574](/filings/0001558370-23-019631.md) | [4,441](/filings/0001558370-25-004329.md) | [4,476](/filings/0001558370-24-009145.md) | [4,611](/filings/0001558370-24-012768.md) | [4,647](/filings/0001558370-24-016185.md) | [4,718](/filings/0001104659-26-037992.md) | [4,761](/filings/0001558370-25-008578.md) | [4,738](/filings/0001558370-25-012015.md) | [4,790](/filings/0001104659-25-120354.md) | [4,775](/filings/0001104659-26-106764.md) | [4,891](/filings/0001104659-26-073006.md) | [5,011](/filings/0001104659-26-106764.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [(333)](/filings/0001558370-24-016185.md) | [(297)](/filings/0001104659-26-037992.md) | [(290)](/filings/0001558370-25-012015.md) | [(235)](/filings/0001104659-25-120354.md) | [(183)](/filings/0001104659-25-120354.md) | [(164)](/filings/0001104659-26-106764.md) | [(111)](/filings/0001104659-26-106764.md) | [(40.9)](/filings/0001104659-26-106764.md) | [3.3](/filings/0001104659-25-120354.md) | [60.6](/filings/0001104659-26-106764.md) | [56.9](/filings/0001104659-26-106764.md) | [120](/filings/0001104659-26-106764.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-10-28) | Q4 FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q4 FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q4 FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [67.8 d](/filings/0001558370-24-016185.md) | [(114) d](/filings/0001104659-26-037992.md) | [56.1](/filings/0001558370-25-008578.md) | [11.2 d](/filings/0001558370-25-012015.md) | [(31.4) d](/filings/0001104659-25-120354.md) | [(18.8) d](/filings/0001104659-26-037992.md) | [86.6](/filings/0001104659-26-073006.md) | [138 d](/filings/0001104659-26-106764.md) | [132 d](/filings/0001104659-25-120354.md) | [96.1 d](/filings/0001104659-26-037992.md) | [52.5](/filings/0001104659-26-073006.md) | [145 d](/filings/0001104659-26-106764.md) |
| Capital expenditure | $m | [50.2 d](/filings/0001558370-24-016185.md) | [138 d](/filings/0001104659-26-037992.md) | [66.3](/filings/0001558370-25-008578.md) | [49.1 d](/filings/0001558370-25-012015.md) | [64.6 d](/filings/0001104659-25-120354.md) | [50.9 d](/filings/0001104659-26-037992.md) | [52.6](/filings/0001104659-26-073006.md) | [57.0 d](/filings/0001104659-26-106764.md) | [48.8 d](/filings/0001104659-25-120354.md) | [41.5 d](/filings/0001104659-26-037992.md) | [39.2](/filings/0001104659-26-073006.md) | [45.6 d](/filings/0001104659-26-106764.md) |
| Share repurchases | $m | [44.6 d](/filings/0001558370-24-016185.md) | [0.0 d](/filings/0001104659-26-037992.md) | not reported | not reported | not reported | [0.0 d](/filings/0001104659-26-037992.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-10-29) | Q1 FY2023 (2023-04-29) | Q2 FY2023 (2023-07-29) | Q3 FY2023 (2023-10-28) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [26.1](/filings/0001558370-23-019631.md) | [23.8](/filings/0001558370-24-009145.md) | [22.7](/filings/0001558370-24-012768.md) | [18.4](/filings/0001558370-24-016185.md) | [18.3](/filings/0001558370-25-008578.md) | [20.0](/filings/0001558370-25-012015.md) | [20.0](/filings/0001104659-25-120354.md) | [19.9](/filings/0001104659-26-073006.md) | [19.7](/filings/0001104659-26-106764.md) | [19.8](/filings/0001104659-25-120354.md) | [18.8](/filings/0001104659-26-073006.md) | [19.7](/filings/0001104659-26-106764.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 18,933,159 at 2026-09-04, from the cover of the [10-Q filed 2026-09-10](/filings/0001104659-26-106764.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.